{"id":3358,"date":"2020-06-09T09:20:53","date_gmt":"2020-06-09T06:20:53","guid":{"rendered":"https:\/\/hansu.av.tr\/?p=3358"},"modified":"2020-10-03T13:21:43","modified_gmt":"2020-10-03T10:21:43","slug":"saglik-hukuku-covid-19-pandemisi-ve-patent-sorunu","status":"publish","type":"post","link":"https:\/\/hansu.av.tr\/tr\/saglik-hukuku-covid-19-pandemisi-ve-patent-sorunu\/","title":{"rendered":"Sa\u011fl\u0131k Hukuku, Covid 19 Pandemisi ve Patent Sorunu"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3358\" class=\"elementor elementor-3358\">\n\t\t\t\t\t\t<div class=\"elementor-inner\">\n\t\t\t\t<div class=\"elementor-section-wrap\">\n\t\t\t\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-5c35878 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"5c35878\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t\t\t<div class=\"elementor-row\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-36e91a5\" data-id=\"36e91a5\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-column-wrap elementor-element-populated\">\n\t\t\t\t\t\t\t<div class=\"elementor-widget-wrap\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-ab15cb8 elementor-widget elementor-widget-text-editor\" data-id=\"ab15cb8\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t<div class=\"elementor-text-editor elementor-clearfix\">\n\t\t\t\t<div><span style=\"color: gray;\">1 Ocak 1995&#8217;te y\u00fcr\u00fcrl\u00fc\u011fe giren Ticaretle \u0130lgili Fikri M\u00fclkiyet Haklar\u0131 Anla\u015fmas\u0131 (\u201cTRIPS Anla\u015fmas\u0131\u201d), farmas\u00f6tik \u00fcr\u00fcnleri patent olarak korunabilecek bir bulu\u015f olarak ilan etmi\u015ftir. TRIPS Anla\u015fmas\u0131na g\u00f6re farmas\u00f6tik bir \u00fcr\u00fcn, patenti al\u0131narak kaydedilip koruma kapsam\u0131na dahil oldu\u011funda \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131slar, s\u00f6z konusu farmas\u00f6tik \u00fcr\u00fcn\u00fcn yasal sahibinin r\u0131zas\u0131 olmadan ilgili \u00fcr\u00fcn\u00fc \u00fcretme, tedarik etme veya satma hakk\u0131na sahip olmamaktad\u0131r. Ne var ki, D\u00fcnya Sa\u011fl\u0131k \u00d6rg\u00fct\u00fc taraf\u0131ndan salg\u0131n hastal\u0131k kategorisine al\u0131nan COVID-19 pandemisi ile t\u0131bbi a\u00e7\u0131dan sava\u015fmak ve hukuki engelleri minimuma indirmek i\u00e7in h\u00fck\u00fcmetler, pandemiye bir yan\u0131t olarak farmas\u00f6tik ve t\u0131bbi \u00fcr\u00fcnler i\u00e7in zorunlu lisanslar\u0131n TRIPS Anla\u015fmas\u0131na ayk\u0131r\u0131 olacak \u015fekilde kullan\u0131lmas\u0131na izin veren mevzuatlar yay\u0131nlamaya ve bu \u015fekilde \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131slar\u0131n kamu sa\u011fl\u0131\u011f\u0131 menfaatini g\u00f6z \u00f6n\u00fcnde tutarak yasal patent sahiplerinin r\u0131zas\u0131 olmadan ilgili \u00fcr\u00fcnlerin kullan\u0131lmas\u0131n\u0131n \u00f6n\u00fcn\u00fc a\u00e7maya ba\u015flam\u0131\u015flard\u0131r. Bu \u015fekilde k\u0131saca, tescilli ve patent ile korunan bir farmas\u00f6tik veya t\u0131bbi \u00fcr\u00fcn herhangi bir hukuka ayk\u0131r\u0131l\u0131k te\u015fkil etmeksizin \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131slarca \u00fcretilmekte, tedarik edilmekte ve sat\u0131lmaktad\u0131r. Bu kapsamda Kanada, \u015eili, Ekvador gibi \u00fclkeler COVID-19 ila\u00e7lar\u0131, a\u015f\u0131lar\u0131 ve di\u011fer t\u0131bbi ara\u00e7 ile cihazlar i\u00e7in zorunlu lisans verme uygulamas\u0131 ba\u015flatarak TRIPS Anla\u015fmas\u0131n\u0131n COVID-19 pandemisi a\u00e7\u0131s\u0131ndan hukuki yapt\u0131r\u0131m sonu\u00e7lar\u0131n\u0131 ortadan kald\u0131rmak i\u00e7in ad\u0131mlar atmaya ba\u015flam\u0131\u015f ve patent sahiplerinin haklar\u0131n\u0131 bir s\u00fcreli\u011fine ortadan kald\u0131rm\u0131\u015flard\u0131r.<\/span><br \/><span style=\"color: gray;\"><br \/><\/span><\/div><p style=\"margin: 0cm 0cm 10pt; line-height: 22px; font-size: 11pt; font-family: Calibri; color: #000000;\"><span lang=\"TR\">H\u00fck\u00fcmetlerin COVID-19 pandemisi ile kamu sa\u011fl\u0131\u011f\u0131n\u0131n \u00fcst\u00fcn menfaati g\u00f6z \u00f6n\u00fcne al\u0131narak bu \u015fekilde sava\u015fmas\u0131 ve salg\u0131n\u0131n hukuki etkilerini minimuma indirmek i\u00e7in patent haklar\u0131n\u0131n da bir s\u00fcreli\u011fine ihlal edilmesinin sa\u011flanmas\u0131 beklenmedik bir durum olu\u015fturmam\u0131\u015ft\u0131r. Zaten baz\u0131 ila\u00e7 firmalar\u0131 da COVID-19 tedavisi i\u00e7in test a\u015famas\u0131nda olan \u00fcr\u00fcnlerinin \u00fczerindeki patent uygulamalar\u0131n\u0131 ask\u0131ya alma yoluna gitmektedirler. \u00d6rne\u011fin Amerika Birle\u015fik Devletleri\u2019nde kurulmu\u015f olan d\u00fcnyan\u0131n en \u00fcnl\u00fc biyofarma \u015firketlerinden ve ila\u00e7 \u00fcreticilerinden biri olan AbbVie, COVID-19 tedavisinde kullan\u0131lmas\u0131 i\u00e7in test a\u015famas\u0131nda olan HIV \/ AIDS&#8217;in tedavisi ve \u00f6nlenmesi i\u00e7in kullan\u0131lan Kaletra ve Aluvia ila\u00e7lar\u0131 \u00fczerindeki patent uygulamalar\u0131n\u0131 ask\u0131ya alm\u0131\u015ft\u0131r. Bu \u015fekilde, \u00fc\u00e7\u00fcnc\u00fc taraflar\u0131n patent ihlali ile su\u00e7lanmadan ilgili ilac\u0131n \u00e7o\u011falt\u0131lmas\u0131na izin verilmesi m\u00fcmk\u00fcn olacak ve \u015fayet ilgili ila\u00e7lar COVID-19 tedavisinde etkili bulunur ise de bu \u00e7o\u011falt\u0131lan versiyonlar\u0131n sat\u0131n al\u0131nmas\u0131 m\u00fcmk\u00fcn olacakt\u0131r.<\/span><\/p><p style=\"margin: 0cm 0cm 10pt; line-height: 22px; font-size: 11pt; font-family: Calibri; color: #000000;\"><span lang=\"TR\">Netice itibari h\u00fck\u00fcmetler, COVID-19 salg\u0131n\u0131n\u0131n toplum sa\u011fl\u0131\u011f\u0131 \u00fczerindeki etkilerini minimuma indirmek ve toplu zararlar\u0131 \u00f6nlemek amac\u0131 g\u00fcderek hukukun di\u011fer alanlar\u0131nda odlu\u011fu gibi fikri m\u00fclkiyet haklar\u0131 kapsam\u0131nda da ad\u0131mlar atm\u0131\u015flard\u0131r. Aslen d\u00fcnyan\u0131n en kapsaml\u0131 anla\u015fmalar\u0131ndan biri olan ve \u00f6zellikle ila\u00e7 sekt\u00f6r\u00fcnde \u00e7ok b\u00fcy\u00fck \u00f6nemi bulunan Fikri M\u00fclkiyet Haklar\u0131n\u0131 Koruma g\u00f6revini \u00fcstlenen TRIPS Anla\u015fmas\u0131 sekt\u00f6r\u00fcn yat\u0131r\u0131m, ara\u015ft\u0131rma ve geli\u015ftirme maliyetlerini geri kazanmak ve tasarrufta bulunmak i\u00e7in de te\u015fvikler de sa\u011flamaktad\u0131r. Her ne kadar toplum menfaati her \u015fekilde h\u00fck\u00fcmetler taraf\u0131ndan en \u00fcst de\u011ferde g\u00f6r\u00fclmekte ise de TRIPS Anla\u015fmas\u0131n\u0131n bu \u015fekilde ihlal edilmesinin ve m\u00fclkiyeti koruyan patentlerin ask\u0131ya al\u0131nmas\u0131n\u0131n y\u00fcksek de\u011ferli ve uzun vadeli yat\u0131r\u0131mlar\u0131n te\u015fvikini azaltaca\u011f\u0131 a\u015fikard\u0131r. Dolay\u0131s\u0131yla b\u00fct\u00fcn h\u00fck\u00fcmetlerin, TRIPS Anla\u015fmas\u0131n\u0131n taraf\u0131 olup olmad\u0131\u011f\u0131na bak\u0131lmaks\u0131z\u0131n patent sahiplerinin haklar\u0131n\u0131 korumak ve zorunlu lisanslar\u0131 \u00f6nlemek ile birlikte ila\u00e7 end\u00fcstrisinde yap\u0131lacak de\u011fi\u015fikliklerin sonu\u00e7lar\u0131n\u0131 minimuma indirmekle m\u00fckellef oldu\u011funu unutmamak gerekir. Zira bu geni\u015f yetki, hem patent sahiplerinin haklar\u0131n\u0131n korunmas\u0131 hem de ba\u015fka bir a\u00e7\u0131dan, h\u00fck\u00fcmet m\u00fcdahalesinin s\u0131n\u0131rlanmas\u0131 ve iktidar ama\u00e7lar\u0131n\u0131n k\u00f6t\u00fcye kullan\u0131lmas\u0131n\u0131n engellenmesi bak\u0131m\u0131ndan da \u00f6nemlidir. TRIPS Anla\u015fmas\u0131n\u0131n bu \u015fekilde ask\u0131ya al\u0131nmas\u0131n\u0131n sonu\u00e7lar\u0131n\u0131 minimuma indirmek i\u00e7in ise ba\u015fvurulabilecek en adil y\u00f6ntemin, uygulamalara zaman s\u0131n\u0131rlamas\u0131 getirilmesi \u015feklinde olaca\u011f\u0131 d\u00fc\u015f\u00fcn\u00fclmektedir.<\/span><span style=\"color: gray;\">\u00a0<\/span><\/p><p><span style=\"color: #666666;\">&#8212;-<\/span><\/p><p><span style=\"font-weight: bold; color: #666666;\">Daha fazla bilgi ve sorular\u0131n\u0131z i\u00e7in:<\/span><\/p><p>www.hansu.av.tr\u00a0|\u00a0+90 216 464 12 12<\/p><p><span style=\"color: #666666;\">-\u00a9 Hansu Hukuk B\u00fcrosu<\/span><\/p><p style=\"margin: 0cm 0cm 10pt; line-height: 22px; font-size: 11pt; font-family: Calibri; color: #000000;\"><span style=\"color: #666666;\">-Hansu Hukuk B\u00fcrosu Yerli ve Yabanc\u0131 m\u00fcvekkillerine \u00f6zellikle gayrimenkul, \u015firketler, vergi, enerji ve fikri m\u00fclkiyet hukuku alan\u0131nda hizmet veren bir avukatl\u0131k b\u00fcrosudur. Bu b\u00fclten T\u00fcrkiye\u2019 de hukuk alan\u0131ndaki geli\u015fmeleri payla\u015fmak amac\u0131yla haz\u0131rlanm\u0131\u015ft\u0131r. B\u00fclten hukuki bir g\u00f6r\u00fc\u015f veya y\u00f6nlendirme olarak d\u00fc\u015f\u00fcn\u00fclmemelidir. \u00d6zel sorular ve sorunlar bak\u0131m\u0131ndan hukuki dan\u0131\u015fman g\u00f6r\u00fc\u015f\u00fc al\u0131nmal\u0131d\u0131r.<\/span><i><span lang=\"TR\">\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/i><\/p>\t\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>1 Ocak 1995&#8217;te y\u00fcr\u00fcrl\u00fc\u011fe giren Ticaretle \u0130lgili Fikri M\u00fclkiyet Haklar\u0131 Anla\u015fmas\u0131 (\u201cTRIPS Anla\u015fmas\u0131\u201d), farmas\u00f6tik \u00fcr\u00fcnleri patent olarak korunabilecek bir bulu\u015f olarak ilan etmi\u015ftir. TRIPS Anla\u015fmas\u0131na g\u00f6re farmas\u00f6tik bir \u00fcr\u00fcn, patenti al\u0131narak kaydedilip koruma kapsam\u0131na dahil oldu\u011funda \u00fc\u00e7\u00fcnc\u00fc \u015fah\u0131slar, s\u00f6z konusu farmas\u00f6tik \u00fcr\u00fcn\u00fcn yasal sahibinin r\u0131zas\u0131 olmadan ilgili \u00fcr\u00fcn\u00fc \u00fcretme, tedarik etme veya satma hakk\u0131na sahip&#8230;<\/p>\n","protected":false},"author":1,"featured_media":4887,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[26,27],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/posts\/3358"}],"collection":[{"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/comments?post=3358"}],"version-history":[{"count":3,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/posts\/3358\/revisions"}],"predecessor-version":[{"id":6436,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/posts\/3358\/revisions\/6436"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/media\/4887"}],"wp:attachment":[{"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/media?parent=3358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/categories?post=3358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hansu.av.tr\/tr\/wp-json\/wp\/v2\/tags?post=3358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}